VentriPoint Diagnostics Ltd.  

(Public, CVE:VPT)   Watch this stock  
Find more results for VPT
0.0000 (0.00%)
Feb 27 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.09 - 0.09
52 week 0.09 - 0.28
Open 0.09
Vol / Avg. 2,700.00/66,807.00
Mkt cap 2.74M
P/E     -
Div/yield     -
EPS -0.01
Shares 32.14M
Beta 0.42
Inst. own     -


100 W Harrison St Ste 410
SEATTLE, WA 98119-4116
United States - Map
+1-206-2830221 (Phone)
+1-425-7474163 (Fax)

Website links


Ventripoint Diagnostics Ltd., formerly Luca Capital Inc., is a medical device company. The Company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates accurate heart volumetric measurements and a three-dimensional (3D) model in a rapid and inexpensive manner. The Company's solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating Knowledge Based Reconstruction (KBR) algorithms and cardiac databases (catalogues). Its technology platform is applicable to all heart diseases. The Company has developed prototype analytical software package to be used with 4D echocardiograms (VMS-4DE) and one to be used with magnetic resonance imaging (MRI) images (VMS-CMR). It also focuses on developing VMS-Plus and the VMS-Nano.

Officers and directors

George Adams President, Chief Executive Officer, Director
Ellen Briant Chief Financial Officer
Alan Rabinowitz Director
Donald H. Segal Ph.D. Director
Age: 68
David A. Willis Director
Danny Dalla-Longa Independent Director